DK0785792T3 - Præparat til behandling af ovariale af østrogen afhængige sygdomme - Google Patents

Præparat til behandling af ovariale af østrogen afhængige sygdomme

Info

Publication number: DK0785792T3
Authority: DK; Denmark
Prior art keywords: preparation; treatment; dependent diseases; estrogen dependent; ovarian estrogen
Prior art date: 1994-02-04

Application number

DK95910179T

Other languages

English (en)

Inventor

Gary D Hodgen

Robert F Williams

Daniel Grow

Original Assignee

Hampton Roads Medical College

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-04

Filing date

1995-02-02

Publication date

1999-10-18

1995-02-02 Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College

1999-10-18 Application granted granted Critical

1999-10-18 Publication of DK0785792T3 publication Critical patent/DK0785792T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK95910179T 1994-02-04 1995-02-02 Præparat til behandling af ovariale af østrogen afhængige sygdomme DK0785792T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/191,631 US5681817A (en)	1994-02-04	1994-02-04	Treatment of ovarian estrogen dependent conditions
PCT/US1995/001479 WO1995020972A1 (en)	1994-02-04	1995-02-02	Treatment of ovarian estrogen dependent conditions

Publications (1)

Publication Number	Publication Date
DK0785792T3 true DK0785792T3 (da)	1999-10-18

Family

ID=22706258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95910179T DK0785792T3 (da)	1994-02-04	1995-02-02	Præparat til behandling af ovariale af østrogen afhængige sygdomme

Country Status (29)

Country	Link
US (1)	US5681817A (da)
EP (1)	EP0785792B1 (da)
JP (1)	JP3130048B2 (da)
KR (1)	KR970700507A (da)
CN (1)	CN1144486A (da)
AP (1)	AP724A (da)
AT (1)	ATE179610T1 (da)
AU (1)	AU689229B2 (da)
BG (1)	BG62238B1 (da)
BR (1)	BR9506606A (da)
CA (1)	CA2182183C (da)
CZ (1)	CZ291709B6 (da)
DE (1)	DE69509544T2 (da)
DK (1)	DK0785792T3 (da)
ES (1)	ES2132645T3 (da)
FI (1)	FI963036L (da)
GR (1)	GR3030164T3 (da)
HU (1)	HUT74622A (da)
LT (1)	LT4182B (da)
LV (1)	LV11782B (da)
MD (1)	MD1432C2 (da)
NZ (1)	NZ281441A (da)
OA (1)	OA10777A (da)
PL (1)	PL178273B1 (da)
RO (1)	RO117420B1 (da)
RU (1)	RU2110274C1 (da)
SK (1)	SK96296A3 (da)
TJ (1)	TJ242B (da)
WO (1)	WO1995020972A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2181598C2 (ru) *	1994-07-22	2002-04-27	Дзе Медикал Колледж оф Хэмптон Роудс	Восстановление тонической секреции эстрогена из яичников для продолжительных схем лечения
US5780435A (en) *	1995-12-15	1998-07-14	Praecis Pharmaceuticals Incorporated	Methods for treating prostate cancer with LHRH-R antagonists
US6274573B1 (en)	1997-10-17	2001-08-14	Mochida Pharmaceutical Co., Ltd.	Method of treatment for uterine leiomyoma
US6703367B1 (en)	1999-04-27	2004-03-09	Praecis Pharmaceuticals Inc.	Methods for treating hot flashes and gynaecomastia
US6355648B1 (en)	1999-05-04	2002-03-12	American Home Products Corporation	Thio-oxindole derivatives
US6423699B1 (en)	1999-05-04	2002-07-23	American Home Products Corporation	Combination therapies using benzimidazolones
US6380178B1 (en)	1999-05-04	2002-04-30	American Home Products Corporation	Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6391907B1 (en)	1999-05-04	2002-05-21	American Home Products Corporation	Indoline derivatives
US6462032B1 (en)	1999-05-04	2002-10-08	Wyeth	Cyclic regimens utilizing indoline derivatives
US6358948B1 (en)	1999-05-04	2002-03-19	American Home Products Corporation	Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6339098B1 (en)	1999-05-04	2002-01-15	American Home Products Corporation	2,1-benzisothiazoline 2,2-dioxides
US6380235B1 (en)	1999-05-04	2002-04-30	American Home Products Corporation	Benzimidazolones and analogues
US6329416B1 (en)	1999-05-04	2001-12-11	American Home Products Corporation	Combination regimens using 3,3-substituted indoline derivatives
US6444668B1 (en)	1999-05-04	2002-09-03	Wyeth	Combination regimens using progesterone receptor modulators
US6306851B1 (en)	1999-05-04	2001-10-23	American Home Products Corporation	Cyclocarbamate and cyclic amide derivatives
US6399593B1 (en)	1999-05-04	2002-06-04	Wyeth	Cyclic regimens using cyclic urea and cyclic amide derivatives
US6509334B1 (en) *	1999-05-04	2003-01-21	American Home Products Corporation	Cyclocarbamate derivatives as progesterone receptor modulators
US6407101B1 (en) *	1999-05-04	2002-06-18	American Home Products Corporation	Cyanopyrroles
US6417214B1 (en) *	1999-05-04	2002-07-09	Wyeth	3,3-substituted indoline derivatives
US6319912B1 (en)	1999-05-04	2001-11-20	American Home Products Corporation	Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6498154B1 (en)	1999-05-04	2002-12-24	Wyeth	Cyclic regimens using quinazolinone and benzoxazine derivatives
US6358947B1 (en)	1999-05-04	2002-03-19	American Home Products Corporation	Tetracyclic progesterone receptor modulator compounds and methods
US6369056B1 (en)	1999-05-04	2002-04-09	American Home Products Corporation	Cyclic urea and cyclic amide derivatives
US8193252B1 (en)	1999-08-31	2012-06-05	Bayer Pharma AG	Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
PT1229906E (pt) *	1999-08-31	2008-01-18	Bayer Schering Pharma Ag	Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos
UA73119C2 (en)	2000-04-19	2005-06-15	American Home Products Corpoir	Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
EP1330257B1 (en) *	2000-10-30	2005-08-31	University Of Zurich	Gnrh analogues for treatment of urinary incontinence
US6960337B2 (en) *	2002-08-02	2005-11-01	Balance Pharmaceuticals, Inc.	Methods and compositions for treating benign gynecological disorders
US6958142B2 (en) *	2002-08-02	2005-10-25	Balance Pharmaceuticals, Inc.	Nasal spray formulation and method
US7029657B2 (en) *	2002-08-02	2006-04-18	Balance Pharmaceuticals, Inc.	Nasal spray steroid formulation and method
GB0302572D0 (en)	2003-02-05	2003-03-12	Astrazeneca Ab	Method of treatment
US8257742B2 (en) *	2005-02-17	2012-09-04	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Bisphosphonates for treating endometriosis
US7862552B2 (en)	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
US20060251581A1 (en) *	2005-05-09	2006-11-09	Mcintyre Jon T	Method for treatment of uterine fibroid tumors
ES2643318T3 (es)	2006-10-24	2017-11-22	Repros Therapeutics Inc.	Composiciones y métodos para suprimir la proliferación endometrial
TWI455716B (zh) *	2006-10-24	2014-10-11	Repros Therapeutics Inc	選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
WO2008144143A1 (en) *	2007-05-14	2008-11-27	Drugtech Corporation	Endometriosis treatment
CA2700253A1 (en) *	2007-09-20	2009-03-21	Bio-Pro Medical Ltd.	Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
RU2359684C1 (ru) *	2008-01-23	2009-06-27	Закрытое акционерное общество "СКАЙ ЛТД"	Способ лечения эндометриоза
US9993427B2 (en)	2013-03-14	2018-06-12	Biorest Ltd.	Liposome formulation and manufacture
EP3560555A1 (en) *	2018-04-26	2019-10-30	LifeArc	A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA8231B (en)	1981-01-09	1982-11-24	Roussel Uclaf	New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en)	1983-06-15	1988-10-25	Schering Aktiengesellschaft	13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de)	1983-12-22	1985-07-11	Schering AG, 1000 Berlin und 4709 Bergkamen	11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
EP0303306B1 (en)	1987-08-08	1993-03-10	Akzo N.V.	Contraceptive implant
DE3744054A1 (de)	1987-12-21	1989-06-29	Schering Ag	Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de)	1989-06-23	1991-01-10	Schering Ag	11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ES2102397T3 (es)	1990-03-16	1997-08-01	Applied Research Systems	Tratamiento de la enfermedad del ovario policistico.
US6827050B2 (en)	2001-12-21	2004-12-07	Caterpillar Inc	Fluid control valve actuating system
US7283632B2 (en)	2003-09-09	2007-10-16	The Boeing Company	Unauthorized access embedded software protection system

1994
- 1994-02-04 US US08/191,631 patent/US5681817A/en not_active Expired - Fee Related
1995
- 1995-02-02 WO PCT/US1995/001479 patent/WO1995020972A1/en not_active Ceased
- 1995-02-02 CA CA002182183A patent/CA2182183C/en not_active Expired - Fee Related
- 1995-02-02 RO RO96-01583A patent/RO117420B1/ro unknown
- 1995-02-02 CN CN95192252A patent/CN1144486A/zh active Pending
- 1995-02-02 PL PL95315792A patent/PL178273B1/pl not_active IP Right Cessation
- 1995-02-02 BR BR9506606A patent/BR9506606A/pt not_active Application Discontinuation
- 1995-02-02 AU AU18386/95A patent/AU689229B2/en not_active Ceased
- 1995-02-02 NZ NZ281441A patent/NZ281441A/en unknown
- 1995-02-02 FI FI963036A patent/FI963036L/fi not_active IP Right Cessation
- 1995-02-02 AT AT95910179T patent/ATE179610T1/de not_active IP Right Cessation
- 1995-02-02 KR KR1019960704226A patent/KR970700507A/ko not_active Ceased
- 1995-02-02 EP EP95910179A patent/EP0785792B1/en not_active Expired - Lifetime
- 1995-02-02 SK SK962-96A patent/SK96296A3/sk unknown
- 1995-02-02 ES ES95910179T patent/ES2132645T3/es not_active Expired - Lifetime
- 1995-02-02 AP APAP/P/1996/000840A patent/AP724A/en active
- 1995-02-02 HU HU9601969A patent/HUT74622A/hu unknown
- 1995-02-02 JP JP07520794A patent/JP3130048B2/ja not_active Expired - Fee Related
- 1995-02-02 MD MD96-0323A patent/MD1432C2/ro unknown
- 1995-02-02 RU RU96118109A patent/RU2110274C1/ru active
- 1995-02-02 DE DE69509544T patent/DE69509544T2/de not_active Expired - Fee Related
- 1995-02-02 DK DK95910179T patent/DK0785792T3/da active
- 1995-02-02 TJ TJ96000402A patent/TJ242B/xx unknown
- 1995-02-02 CZ CZ19962103A patent/CZ291709B6/cs not_active IP Right Cessation
1996
- 1996-07-29 OA OA60870A patent/OA10777A/en unknown
- 1996-08-01 BG BG100766A patent/BG62238B1/bg unknown
- 1996-09-03 LV LVP-96-354A patent/LV11782B/en unknown
- 1996-09-04 LT LT96-133A patent/LT4182B/lt not_active IP Right Cessation
1999
- 1999-05-07 GR GR990401145T patent/GR3030164T3/el unknown

Also Published As

Publication number	Publication date
US5681817A (en)	1997-10-28
WO1995020972A1 (en)	1995-08-10
LV11782A (lv)	1997-06-20
AU689229B2 (en)	1998-03-26
LT4182B (en)	1997-06-25
NZ281441A (en)	1999-09-29
RU2110274C1 (ru)	1998-05-10
BG62238B1 (bg)	1999-06-30
AP9600840A0 (en)	1996-07-31
LV11782B (en)	1997-12-20
MD1432B2 (en)	2000-03-31
OA10777A (en)	2002-12-23
RO117420B1 (ro)	2002-03-29
SK96296A3 (en)	1997-07-09
AU1838695A (en)	1995-08-21
CZ291709B6 (cs)	2003-05-14
AP724A (en)	1999-01-18
ES2132645T3 (es)	1999-08-16
EP0785792A1 (en)	1997-07-30
HU9601969D0 (en)	1996-09-30
PL178273B1 (pl)	2000-03-31
BR9506606A (pt)	1997-09-09
FI963036A0 (fi)	1996-08-01
FI963036A7 (fi)	1996-08-01
CA2182183A1 (en)	1995-08-10
DE69509544D1 (de)	1999-06-10
EP0785792A4 (da)	1997-07-30
PL315792A1 (en)	1996-12-09
JP3130048B2 (ja)	2001-01-31
KR970700507A (ko)	1997-02-12
JPH09508418A (ja)	1997-08-26
LT96133A (en)	1997-01-27
CN1144486A (zh)	1997-03-05
BG100766A (bg)	1997-06-30
CA2182183C (en)	2003-09-16
CZ210396A3 (en)	1997-05-14
MD1432C2 (ro)	2000-09-30
GR3030164T3 (en)	1999-08-31
EP0785792B1 (en)	1999-05-06
DE69509544T2 (de)	1999-09-02
HUT74622A (en)	1997-01-28
FI963036L (fi)	1996-08-01
ATE179610T1 (de)	1999-05-15
TJ242B (en)	1999-11-24

Publication	Publication Date	Title
DK0785792T3 (da)	1999-10-18	Præparat til behandling af ovariale af østrogen afhængige sygdomme
DK0770615T3 (da)	2003-07-14	Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK1032566T3 (da)	2003-06-10	Fremgangsmåde til fremstilling af citalopram
DK0941103T3 (da)	2002-04-15	Farmaceutisk præparat til behandling af diabetes
DK0812357T3 (da)	2007-05-14	Fremgangsmåde til fremstilling af heteromultimere polypeptider
DK0820276T3 (da)	2003-03-17	Fremgangsmåde til fremstilling af respirerbare partikler
DK0747116T3 (da)	2001-11-26	Fremgangsmåde til fremstilling af mikrokapselsammensætninger
DK0807086T3 (da)	1999-12-27	Fremgangsmåde til fremstilling af hydrotalciter
FI973281L (fi)	1997-08-08	Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
DK0775100T3 (da)	2000-11-27	Fremgangsmåde til fremstilling af trifluorethylen
DK0670835T3 (da)	2003-06-23	Fremgangsmåde til fremstilling af benzopyranforbindelser
DK0839138T3 (da)	2004-09-27	Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0768310T3 (da)	2000-04-17	Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0756597T3 (da)	2001-08-20	Fremgangsmåde til fremstilling af puriner
DK0877738T3 (da)	2003-09-08	Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0873326T3 (da)	2006-03-27	Fremgangsmåde til fremstilling af 2-chlorthiazolforbindelser
DK1028960T3 (da)	2003-08-11	Fremgangsmåde til fremstilling af thiazolidinedion
DK0946531T3 (da)	2006-02-13	Fremgangsmåde til fremstilling af thiazol-derivater
DK0923599T3 (da)	2002-04-22	Fremgangsmåde til fremstilling af 17-estere af 9alfa, 21-dihalogenpregnan-11beta, 17alfa-diol-20-oner
DK0946514T3 (da)	2003-08-25	Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0880498T3 (da)	2002-05-21	Fremgangsmåde til fremstilling af diketonforbindelser
DK0648738T3 (da)	1997-06-16	Fremgangsmåde til fremstilling af acetoacetarylamider
DK0815092T3 (da)	1999-12-06	Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK0846691T3 (da)	2004-11-01	Fremgangsmåde til fremstilling af 3-(1-hydroxyphenyl-1-alkoximinomethyl)dioxaziner
DK1012152T3 (da)	2003-02-10	Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer